Core Insights - Nu Skin Enterprises, Inc. (NUS) reported fourth-quarter 2024 results with earnings surpassing estimates, while net sales declined year over year [1][2] - The company anticipates improving trends in several markets for 2025 but expects economic challenges in Greater China and South Korea [1] Financial Performance - Adjusted earnings for Q4 were 38 cents per share, up from 37 cents in the previous year, beating the Zacks Consensus Estimate of 22 cents [2] - Quarterly revenues were 445.6million,down8.8317.9 million, with an adjusted gross margin of 71.4%, down 70 basis points from the prior year [5] - Selling expenses declined 8.8% to 165.4million,remainingflatasapercentageofrevenuesat37.1120.9 million, with a percentage of revenues at 27.1%, down 260 basis points [7] - Adjusted operating income increased 10.1% year over year to 34.5million,withanadjustedoperatingmarginof7.7186.9 million, long-term debt of 363.6million,andtotalstockholders′equityof651.5 million [9] - The company declared a cash dividend of 6 cents per share, payable on March 5, 2025 [10] Future Outlook - For 2025, Nu Skin anticipates revenues between 1.48billionand1.62 billion, indicating a decline of 15-6% from the previous year [12] - EPS for 2025 is projected to be between 3.45and3.85, or 90 cents to 1.30whenexcludinggainsfromtheMavelytransaction[13]−ForQ12025,revenuesareexpectedtobebetween345 million and $365 million, representing a decline of 17% to 13% [13]